Skip to main content
logo
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.090
+0.020 (1.87%)
At close: Jun 22, 2026, 4:00 PM EDT
1.100
+0.010 (0.92%)
After-hours: Jun 22, 2026, 7:56 PM EDT

Akebia Therapeutics Revenue

Akebia Therapeutics had revenue of $53.54M in the quarter ending March 31, 2026, a decrease of -6.61%. This brings the company's revenue in the last twelve months to $232.40M, up 25.69% year-over-year. In the year 2025, Akebia Therapeutics had annual revenue of $236.20M with 47.46% growth.

Revenue (ttm)
$232.40M
Revenue Growth
+25.69%
P/S Ratio
1.26
Revenue / Employee
$1,197,959
Employees
194
Market Cap
292.40M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025236.20M76.02M47.46%
Dec 31, 2024160.18M-34.44M-17.70%
Dec 31, 2023194.62M-97.86M-33.46%
Dec 31, 2022292.48M80.83M38.19%
Dec 31, 2021211.65M-82.99M-28.17%
Dec 31, 2020294.64M-40.36M-12.05%
Dec 31, 2019335.00M127.26M61.26%
Dec 31, 2018207.74M26.52M14.63%
Dec 31, 2017181.23M179.69M11,706.32%
Dec 31, 20161.54M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Emergent BioSolutions676.80M
Organogenesis Holdings514.70M
Evolus301.79M
Aurora Cannabis229.67M
Canopy Growth203.89M
Kamada181.68M
Lifecore Biomedical129.46M
Anika Therapeutics116.26M
Revenue Rankings

AKBA News

More News